Ultralife (NASDAQ:ULBI) Receives “Buy” Rating from Benchmark

Benchmark reissued their buy rating on shares of Ultralife (NASDAQ:ULBIFree Report) in a research report sent to investors on Friday,Benzinga reports. The brokerage currently has a $14.00 price target on the technology company’s stock.

Separately, StockNews.com lowered shares of Ultralife from a “strong-buy” rating to a “buy” rating in a report on Thursday, October 3rd.

Check Out Our Latest Analysis on ULBI

Ultralife Price Performance

Ultralife stock opened at $7.54 on Friday. Ultralife has a 12 month low of $6.36 and a 12 month high of $13.39. The company has a current ratio of 3.30, a quick ratio of 1.62 and a debt-to-equity ratio of 0.04. The business’s 50 day simple moving average is $8.94 and its 200 day simple moving average is $10.20. The company has a market cap of $125.39 million, a price-to-earnings ratio of 13.71 and a beta of 0.98.

Institutional Investors Weigh In On Ultralife

Several institutional investors and hedge funds have recently made changes to their positions in ULBI. O Shaughnessy Asset Management LLC purchased a new position in shares of Ultralife during the 1st quarter worth $100,000. Barclays PLC lifted its stake in shares of Ultralife by 21.3% during the 3rd quarter. Barclays PLC now owns 13,395 shares of the technology company’s stock valued at $121,000 after buying an additional 2,355 shares in the last quarter. Rhumbline Advisers lifted its stake in Ultralife by 1,728.3% in the 2nd quarter. Rhumbline Advisers now owns 11,811 shares of the technology company’s stock worth $125,000 after purchasing an additional 11,165 shares in the last quarter. Perritt Capital Management Inc. lifted its stake in Ultralife by 25.0% in the 1st quarter. Perritt Capital Management Inc. now owns 15,000 shares of the technology company’s stock worth $132,000 after purchasing an additional 3,000 shares in the last quarter. Finally, Juncture Wealth Strategies LLC purchased a new stake in Ultralife in the 3rd quarter worth $165,000. Institutional investors own 30.68% of the company’s stock.

About Ultralife

(Get Free Report)

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.

Featured Articles

Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.